Supplemental material
Open access
3,296
Views
25
CrossRef citations to date
0
Altmetric
Original Articles
Antiviral potential of human IFN-α subtypes against influenza A H3N2 infection in human lung explants reveals subtype-specific activities
Aline da Rocha Matosa Institute of Virology Muenster, Westfaelische Wilhelms-University, Muenster, Germany;b Respiratory Viruses and Measles Lab, Oswaldo Cruz Institute, Fiocruz, Rio de Janeiro, BrazilView further author information
, Katharina Wunderlicha Institute of Virology Muenster, Westfaelische Wilhelms-University, Muenster, GermanyView further author information
, Sebastian Schloerc Institute of Medical Biochemistry, Westfaelische Wilhelms-University, Muenster, GermanyView further author information
, Klaus Schughartd Department of Infection Genetics, Helmholtz Centre for Infection Research, Braunschweig, GermanyView further author information
, Robert Gefferse Genome analytics, Helmholtz Centre for Infection Research, Braunschweig, GermanyView further author information
, Martine Sedersa Institute of Virology Muenster, Westfaelische Wilhelms-University, Muenster, GermanyView further author information
, Marlous de Witta Institute of Virology Muenster, Westfaelische Wilhelms-University, Muenster, GermanyView further author information
, Anmari Christerssona Institute of Virology Muenster, Westfaelische Wilhelms-University, Muenster, GermanyView further author information
, Rainer Wiewrodtf Department of Medicine A, Hematology, Oncology and Respiratory Medicine, University Hospital Muenster, Muenster, GermanyView further author information
, Karsten Wiebeg Department of Thoracic Surgery, University Hospital Muenster, Muenster, GermanyView further author information
, Peter Barthh Gerhard-Domagk-Institute of Pathology, Westfaelische Wilhelms-University, Muenster, GermanyView further author information
, Andreas Hockei Charité – Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Department of Internal Medicine/Infectious Diseases and Respiratory Medicine, Berlin, GermanyView further author information
, Stefan Hippenstieli Charité – Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Department of Internal Medicine/Infectious Diseases and Respiratory Medicine, Berlin, GermanyView further author information
, Katja Hönzkei Charité – Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Department of Internal Medicine/Infectious Diseases and Respiratory Medicine, Berlin, GermanyView further author information
, Ulf Dittmerj Institute for Virology, University Hospital Essen, University of Duisburg-Essen, Duisburg, GermanyView further author information
, Kathrin Sutterj Institute for Virology, University Hospital Essen, University of Duisburg-Essen, Duisburg, GermanyView further author information
, Ursula Rescherc Institute of Medical Biochemistry, Westfaelische Wilhelms-University, Muenster, GermanyView further author information
, Svetlana Rodionychevag Department of Thoracic Surgery, University Hospital Muenster, Muenster, GermanyView further author information
, Nicoletta Materag Department of Thoracic Surgery, University Hospital Muenster, Muenster, GermanyView further author information
, Stephan Ludwiga Institute of Virology Muenster, Westfaelische Wilhelms-University, Muenster, Germany
https://orcid.org/0000-0003-4490-3052View further author information
Linda Brunottea Institute of Virology Muenster, Westfaelische Wilhelms-University, Muenster, GermanyCorrespondence[email protected]
https://orcid.org/0000-0001-8074-7400View further author information
Pages 1763-1776
|
Received 22 Jul 2019, Accepted 21 Nov 2019, Published online: 11 Dec 2019
Related Research Data
Targeting cell signalling pathways to fight the flu: towards a paradigm change in anti-influenza therapy
Source:
Oxford University Press (OUP)
Human lung ex vivo infection models.
Source:
Springer Science and Business Media LLC
Peginterferon and Ribavirin for Chronic Hepatitis C
Source:
Massachusetts Medical Society
Different antiviral effects of IFNα subtypes in a mouse model of HBV infection.
Source:
Springer Science and Business Media LLC
Exogenous IFN-alpha administration reduces influenza A virus replication in the lower respiratory tract of rhesus macaques.
Source:
eScholarship, University of California
Virus susceptibility and clinical effectiveness of anti-influenza drugs during the 2010–2011 influenza season in Russia
Source:
The Authors. Published by Elsevier Ltd.
Multilayered regulations of RIG-I in the anti-viral signaling pathway.
Source:
Springer Science and Business Media LLC
Intranasal Administration of Alpha Interferon Reduces Seasonal Influenza A Virus Morbidity in Ferrets
Source:
HAL CCSD
Intranasally administered interferon as prophylaxis against experimentally induced influenza A virus infection in humans.
Source:
Oxford University Press (OUP)
Antiviral potential of human IFN-α subtypes against influenza A H3N2 infection in human lung explants reveals subtype-specific activities
Source:
Figshare
Antiviral susceptibility of influenza viruses isolated from patients pre- and post-administration of favipiravir.
Source:
Elsevier BV
Structure of the Human Type-I Interferon Gene Cluster Determined from a YAC Clone Contig
Source:
Elsevier BV
Efficacy and Tolerance of Intranasally Applied Recombinant Leukocyte A Interferon in Normal Volunteers
Source:
Oxford University Press (OUP)
The RNA sensor RIG-I dually functions as an innate sensor and direct antiviral factor for hepatitis B virus
Source:
Elsevier BV
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.